Investor Presentaiton

9M 2020 Reconciliation From Management Key Metrics To IFRS €m Management View Adjusted P&L Deferred Revenue D&A Other non-IFRS Adjustments Billings / Revenue 332.1 2.5 Accounting View IFRS P&L 334.6 Cost Of Sales (26.3)/(7.9% of Billings) (19.9) (0.4) Gross Profit Contribution 305.8/(92.1% of Billings) Sales (41.5)/(12.5% of Billings) (3.6) (7.5) (46.6)/(13.9% of Revenue) 288.0/(86.1% of Revenue) (52.6)/ (15.7% of Revenue) Marketing (21.8)/(6.6% of Billings) (1.0) (4.4) R&D (24.2)/(7.3)% of Billings) (3.7) (3.4) G&A (19.0)/(5.7% of Billings) (1.5) (21.9) Other¹ (10.1)/ (3.0% of Billings) 1.1 (27.2)/(8.1% of Revenue) (31.2)/(9.3% of Revenue) (42.3)/ (12.7% of Revenue) (9.0)/(2.7% of Revenue) Adj. EBITDA D&A (ordinary only)2 189.3 (57.0% of Billings) (11.6)2 Adj. EBIT/Operating profit (EBIT) 177.7 / (53.5% of Billings) 2.5 (18.0) 3 (36.5) 125.7 / (37.6% of Revenue) D&A (total) EBITDA 1) incl. other income/expenses and bad debt expenses of €10.8m 2) D&A excl. amortization intangible assets from PPA 3) Amortization intangible assets from PPA 20 Q3 2020 Investor Presentation 29.6 155.3/ (46.4% of Revenue) TeamViewer

View entire presentation